Complete Filing Data
Beneficient reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $1.73 billion for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Beneficient did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Net Income * | -$803.0K | -$2.66B | -$252.1M | -$105.1M | -$50.9M |
| Revenues Excluding Interest And Dividends | -$6.5M | $4.8M | -$54.0M | $15.5M | $132.6M |
| Revenues | -$7.9M | -$98.7M | -$104.9M | $55.3M | $140.3M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$278.0K | $4.1M | $11.2M | -$1.4M | $0.00 |
| Operating Expenses | $16.2M | $2.55B | $148.3M | $126.4M | $187.7M |
| Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest | -$13.2M | -$2.67B | -$263.6M | -$96.9M | -$15.0M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $50.9M | -$2.09B | -$119.8M | -$96.5M | -$58.0M |
| Comprehensive Income Net Of Tax | $51.2M | -$2.10B | -$131.0M | -$95.0M | -$58.0M |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest | -$278.0K | $4.1M | $11.2M | -$1.4M | $0.00 |
| Operating Income Loss | -$24.2M | -$2.65B | -$253.2M | -$71.1M | -$47.4M |
| Net Income Loss Available To Common Stockholders Basic | $51.2M | -$2.10B | -$131.0M | -$95.0M | -$58.0M |
| Income Tax Expense Benefit | $80.0K | $788.0K | -$1.1M | $0.00 | $3.5M |
| Provision For Other Credit Losses Other Than Temporary Impairment And Trade Receivable Write Offs | $1.0M | $6.0M | $20.6M | $18.8M | $0.00 |
| Trust Services And Administration Revenues | $753.0K | $365.0K | $30.0K | $540.0K | $30.0K |
| Net Income Loss Attributable To Noncontrolling Interest | -$69.8M | -$579.3M | -$136.9M | -$43.4M | $7.2M |
| Goodwill Impairment Loss | $3.7M | $2.35B | $0.00 | ||
| Deferred Income Tax Expense Benefit | $80.0K | $0.00 | -$1.1M | $0.00 | $3.5M |
| Other Nonoperating Income | $2.0K | $212.0K | $86.0K | $2.0K | $36.3M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$723.0K | -$2.66B | -$253.2M | -$105.1M | -$47.4M |
| Interest Expense | $17.6M | $15.5M | $27.5M | $32.6M | |
| Interest Expense Operating | $14.9M | $17.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $19.9M | -$17.9M | -$92.6M | -$8.6M | $9.7M | $44.3M | -$924.9M | -$381.8M | -$1.16B | -$42.9M | -$73.9M | -$86.3M | -$100.9M | -$23.0M |
| Revenues Excluding Interest And Dividends | -$25.4M | -$3.2M | -$12.8M | $4.7M | $8.5M | $11.0M | $7.4M | -$13.0K | $500.0K | $11.5M | -$17.1M | -$25.1M | -$10.8M | $2.1M |
| Revenues | $18.7M | -$2.8M | -$12.6M | $4.4M | $8.6M | $10.0M | -$10.2M | -$42.8M | -$2.7M | -$11.4M | -$37.9M | -$37.0M | -$66.6M | $2.4M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$38.0K | $92.0K | $0.00 | -$120.0K | $26.0K | -$21.0K | $51.0K | -$105.0K | $4.3M | -$1.3M | $9.5M | -$1.8M | $110.0K | $0.00 |
| Operating Expenses | $14.7M | $15.1M | $80.0M | $13.9M | $22.3M | -$34.3M | $905.7M | $339.0M | $1.15B | $33.8M | $35.1M | $48.9M | $33.2M | $25.6M |
| Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest | $4.2M | -$19.6M | -$94.3M | -$12.2M | $5.3M | $40.0M | -$929.1M | -$385.9M | -$1.16B | -$46.0M | -$76.6M | -$88.7M | -$103.4M | -$20.0M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $19.9M | -$3.5M | -$65.1M | -$8.8M | $12.9M | $47.6M | -$542.1M | -$371.8M | -$1.11B | -$38.2M | $4.3M | -$55.8M | -$44.3M | -$6.8M |
| Comprehensive Income Net Of Tax | $19.9M | -$3.6M | -$65.1M | -$8.6M | $12.9M | $47.7M | -$542.2M | -$371.7M | -$1.12B | -$36.9M | -$5.2M | -$54.0M | -$44.4M | -$6.8M |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest | -$38.0K | $92.0K | $0.00 | -$120.0K | $26.0K | -$21.0K | $51.0K | -$105.0K | $4.3M | -$1.3M | $9.5M | -$1.8M | $110.0K | $0.00 |
| Operating Income Loss | $3.9M | -$17.9M | -$9.5M | -$13.7M | -$916.0M | -$381.8M | -$1.16B | -$45.2M | -$73.0M | -$86.0M | -$99.8M | -$23.2M | ||
| Net Income Loss Available To Common Stockholders Basic | -$3.6M | -$65.1M | -$8.6M | $12.9M | $47.7M | -$542.2M | -$371.7M | -$1.12B | -$36.9M | -$5.2M | -$54.0M | -$44.4M | -$6.8M | |
| Income Tax Expense Benefit | $0.00 | $43.0K | $0.00 | $713.0K | $0.00 | $28.0K | $75.0K | $0.00 | $0.00 | -$2.4M | $887.0K | $397.0K | $1.1M | -$273.0K |
| Provision For Other Credit Losses Other Than Temporary Impairment And Trade Receivable Write Offs | $0.00 | $0.00 | $0.00 | $0.00 | $476.0K | $524.0K | $0.00 | $0.00 | $0.00 | $1.8M | -$10.0K | $18.8M | $9.4M | $0.00 |
| Trust Services And Administration Revenues | $188.0K | $178.0K | $188.0K | $188.0K | $187.0K | $189.0K | $158.0K | -$87.0K | $102.0K | $8.0K | $8.0K | $8.0K | $129.0K | |
| Net Income Loss Attributable To Noncontrolling Interest | -$18.7M | -$19.0M | -$32.2M | -$6.1M | -$7.6M | -$7.7M | -$386.9M | -$14.2M | -$44.6M | -$9.9M | -$72.7M | -$36.2M | -$60.3M | |
| Goodwill Impairment Loss | $0.00 | $0.00 | $0.00 | $0.00 | $298.0K | $3.4M | $883.2M | $306.7M | $1.10B | $0.00 | $0.00 | $0.00 | ||
| Deferred Income Tax Expense Benefit | $0.00 | $397.0K | $1.1M | -$273.0K | ||||||||||
| Other Nonoperating Income | $0.00 | $2.0K | $65.0K | $0.00 | $0.00 | $86.0K | $2.0K | $0.00 | ||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $5.9M | -$17.9M | -$92.6M | -$9.5M | $9.7M | $44.3M | -$924.8M | -$381.8M | -$1.16B | -$45.2M | ||||
| Interest Expense | $4.7M | $5.1M | $3.8M | $4.1M | $3.6M | $3.6M | $2.1M | |||||||
| Interest Expense Operating | $5.8M | $4.9M | $3.4M | $3.2M | $4.3M | $4.3M | $4.7M | $5.1M | $3.8M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | $1.73B | $1.91B | $1.09B | $986.3M | $676.5M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $9.5M | $76.1M | $20.3M | $17.9M | $34.0M | ||
| Gain Loss On Investments | -$2.2M | -$104.5M | -$51.4M | $31.8M | -$30.7M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$6.6M | -$1.6M | -$66.6M | $2.4M | -$16.1M | ||
| Goodwill | $13.6M | $2.37B | $2.37B | $2.37B | $2.37B | $2.37B | |
| Minority Interest Decrease From Distributions To Noncontrolling Interest Holders | $269.0K | $131.0K | $1.5M | $737.0K | |||
| Amortization Of Debt Discount Premium | $296.0K | -$1.3M | -$4.5M | ||||
| Repayments Of Loans Payable | $4.7M | $6.8M | $17.9M | ||||
| Equity Method Investment Dividends Or Distributions | $0.00 | $12.4M | $8.7M | $3.7M | |||
| Temporary Equity Guaranteed Payment Accrual | $5.4M | -$16.8M | -$15.8M | $1.3M | |||
| Treasury Stock Common Value | $3.4M | $3.4M | $3.4M | ||||
| Treasury Stock Common Shares | 9.0K | 9.0K | 544.0K | ||||
| Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | $251.1M | $950.5M | $1.91B | ||||
| Minority Interest | $42.2M | $142.2M | $277.9M | ||||
| Liabilities And Stockholders Equity | $368.5M | $2.91B | $3.14B | ||||
| Liabilities | $309.6M | $231.8M | $241.4M | ||||
| Cash And Cash Equivalents At Carrying Value | $7.9M | $8.7M | $70.6M | ||||
| Assets | $368.5M | $2.91B | $3.14B | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $276.0K | $9.9M | -$1.3M | ||||
| Other Liabilities | $31.7M | $14.6M | $12.4M | ||||
| Other Assets | $14.7M | $32.9M | $19.9M | ||||
| Restricted Cash | $0.00 | $64.0K | $819.0K | $5.5M | |||
| Repayments Of Related Party Debt | $0.00 | $750.0K | $0.00 | $75.4M | |||
| Gains Losses On Extinguishment Of Debt | $0.00 | -$8.8M | $0.00 | -$34.0M | $0.00 | ||
| Retained Earnings Accumulated Deficit | -$2.06B | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -$128.6M | -$142.8M | -$120.4M | -$34.9M | $14.3M | -$13.2M | -$148.3M | -$192.1M | $4.0M | $932.3M | $1.28B | $1.77B | $1.81B | $1.84B | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $7.9M | $4.9M | $7.6M | $1.3M | $4.2M | $4.8M | $4.7M | $8.0M | $11.3M | $2.4M | $3.9M | $15.4M | $21.7M | $39.2M | ||
| Gain Loss On Investments | $43.8M | $211.0K | -$45.0K | -$523.0K | -$179.0K | -$1.2M | -$18.0M | -$42.8M | -$3.5M | -$23.0M | -$21.0M | -$12.0M | -$56.0M | -$2.2M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $6.3M | -$3.3M | -$5.7M | -$36.9M | $55.8M | -$129.0K | ||||||||||
| Goodwill | $9.9M | $9.9M | $9.9M | $9.9M | $9.9M | $9.9M | $10.2M | $81.7M | $964.9M | $1.27B | ||||||
| Minority Interest Decrease From Distributions To Noncontrolling Interest Holders | $436.0K | $410.0K | $921.0K | $135.0K | $122.0K | $225.0K | $269.0K | $238.0K | $329.0K | $131.0K | $543.0K | $811.0K | $621.0K | |||
| Amortization Of Debt Discount Premium | $92.0K | $38.0K | -$1.3M | |||||||||||||
| Repayments Of Loans Payable | $10.5M | $0.00 | $3.1M | $4.8M | $3.8M | $0.00 | ||||||||||
| Equity Method Investment Dividends Or Distributions | $0.00 | $45.0K | $173.0K | $551.0K | ||||||||||||
| Temporary Equity Guaranteed Payment Accrual | $3.0M | $3.0M | $3.0M | $2.5M | $4.4M | -$4.1M | -$3.9M | $3.8M | ||||||||
| Treasury Stock Common Value | $3.4M | $3.4M | $3.4M | $3.4M | $3.4M | $3.4M | $3.4M | $3.4M | $3.4M | $3.4M | ||||||
| Treasury Stock Common Shares | 1.0K | 9.0K | 9.0K | 1.0K | 9.0K | 9.0K | 9.0K | 544.0K | 544.0K | 544.0K | ||||||
| Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | $90.5M | $90.5M | $90.5M | $90.5M | $90.5M | $125.5M | $251.1M | $251.1M | $251.1M | $251.1M | ||||||
| Minority Interest | $51.2M | $80.1M | $99.4M | $132.1M | $180.9M | $152.1M | $34.3M | $176.2M | $563.6M | $786.1M | ||||||
| Liabilities And Stockholders Equity | $337.9M | $316.2M | $334.5M | $354.9M | $400.0M | $368.8M | $361.3M | $500.6M | $1.46B | $1.80B | ||||||
| Liabilities | $375.9M | $368.5M | $364.4M | $299.3M | $295.2M | $256.5M | $258.5M | $245.5M | $273.7M | $263.9M | ||||||
| Cash And Cash Equivalents At Carrying Value | $7.9M | $4.9M | $7.6M | $1.3M | $4.1M | $4.5M | $4.4M | $11.2M | $2.4M | $3.1M | ||||||
| Assets | $337.9M | $316.2M | $334.5M | $354.9M | $400.0M | $368.8M | $361.3M | $500.6M | $1.46B | $1.80B | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $52.0K | $90.0K | -$2.0K | -$2.0K | $161.0K | $281.0K | $255.0K | $442.0K | $391.0K | $14.2M | ||||||
| Other Liabilities | $33.3M | $29.9M | $26.9M | $24.4M | $22.4M | $19.1M | $34.8M | $21.0M | $17.0M | |||||||
| Other Assets | $55.0M | $54.3M | $50.1M | $49.1M | $48.5M | $16.0M | $11.9M | $26.1M | $28.8M | |||||||
| Restricted Cash | $52.0K | $314.0K | $314.0K | $20.0K | $20.0K | $821.0K | ||||||||||
| Repayments Of Related Party Debt | $4.4M | $0.00 | ||||||||||||||
| Gains Losses On Extinguishment Of Debt | $0.00 | -$8.8M | $0.00 | $0.00 | ||||||||||||
| Retained Earnings Accumulated Deficit | -$2.06B | -$2.08B | -$2.07B | -$2.01B | -$2.01B | -$2.00B | -$2.01B | -$1.99B | -$1.45B | -$1.08B |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital | $46.3M | $72.6M | $51.4M | $20.4M | |
| Share Based Compensation | $5.6M | $39.1M | $10.1M | $23.2M | $107.8M |
| Payments To Acquire Property Plant And Equipment | $1.1M | $1.8M | $2.1M | $4.2M | $3.2M |
| Net Cash Provided By Used In Operating Activities | -$37.7M | -$58.2M | -$95.1M | -$57.0M | -$54.0M |
| Net Cash Provided By Used In Investing Activities | $28.1M | $44.1M | $63.0M | $44.6M | -$6.0M |
| Net Cash Provided By Used In Financing Activities | $3.0M | $12.6M | -$34.5M | $14.9M | $43.9M |
| Increase Decrease In Other Operating Assets | $32.8M | -$6.0M | $13.0M | $17.0M | $2.3M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $41.4M | $8.6M | $11.2M | $5.2M | $2.0M |
| Depreciation Depletion And Amortization | $1.7M | $3.8M | $3.6M | $2.0M | $1.1M |
| Payments Of Stock Issuance Costs | $2.1M | $8.1M | $6.1M | $517.0K | $633.0K |
| Increase Decrease In Other Operating Liabilities | $0.00 | $2.6M | -$319.0K | -$501.0K | -$207.0K |
| Adjustments Related To Tax Withholding For Share Based Compensation | $116.0K | $1.1M | $1.5M | $1.5M | |
| Payments Related To Tax Withholding For Share Based Compensation | $0.00 | $116.0K | $1.1M | $1.5M | $1.6M |
| Payments Of Debt Issuance Costs | $0.00 | $1.6M | $0.00 | $1.1M | $3.2M |
| Payments For Purchase Of Put Options | $0.00 | $7.5M | $0.00 | $14.8M | |
| Payments To Minority Shareholders | $0.00 | $269.0K | $131.0K | $0.00 | $5.6M |
| Payments To Acquire Investments | $1.2M | $1.4M | $2.6M | ||
| Proceeds From Sale Of Put Options | $0.00 | $968.0K | $1.0M | $1.8M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2025 | Q2 2024 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital | $3.7M | $7.2M | $12.0M | $19.3M | $13.3M | $9.5M | |||
| Share Based Compensation | $461.0K | $994.0K | $27.0M | $3.5M | $2.8M | $5.0M | |||
| Payments To Acquire Property Plant And Equipment | $96.0K | $664.0K | $523.0K | $338.0K | $975.0K | $720.0K | |||
| Net Cash Provided By Used In Operating Activities | -$10.8M | -$10.6M | -$13.9M | -$37.1M | -$11.3M | -$17.7M | |||
| Net Cash Provided By Used In Investing Activities | $26.5M | $6.4M | $11.2M | $10.6M | $11.5M | $4.3M | |||
| Net Cash Provided By Used In Financing Activities | -$9.4M | $991.0K | -$3.0M | -$10.4M | $55.6M | $13.3M | |||
| Increase Decrease In Other Operating Assets | -$1.1M | -$1.9M | $1.1M | $11.4M | -$10.0M | -$256.0K | |||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $1.6M | -$565.0K | $12.0M | -$1.6M | -$1.0M | -$5.2M | |||
| Depreciation Depletion And Amortization | $242.0K | $414.0K | $931.0K | $777.0K | $612.0K | $512.0K | |||
| Payments Of Stock Issuance Costs | $0.00 | $1.6M | $3.2M | $785.0K | $0.00 | $185.0K | |||
| Increase Decrease In Other Operating Liabilities | $0.00 | -$92.0K | $256.0K | $39.0K | -$63.0K | -$45.0K | |||
| Adjustments Related To Tax Withholding For Share Based Compensation | $32.0K | $84.0K | $61.0K | $32.0K | $992.0K | $33.0K | $1.2M | ||
| Payments Related To Tax Withholding For Share Based Compensation | $0.00 | $84.0K | $992.0K | $33.0K | $1.2M | ||||
| Payments Of Debt Issuance Costs | $8.6M | $100.0K | |||||||
| Payments For Purchase Of Put Options | $0.00 | $7.5M | $0.00 | $0.00 | |||||
| Payments To Minority Shareholders | $0.00 | $0.00 | |||||||
| Payments To Acquire Investments | $1.2M | $192.0K | $256.0K | $948.0K | |||||
| Proceeds From Sale Of Put Options |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2021 | FY2020 |
|---|---|---|---|---|
| Preferred Stock Shares Authorized | 250.0M | 250.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | ||
| Earnings Per Share Diluted | $-1.94 | $-1.84 | $-1.27 | |
| Earnings Per Share Basic | $-1.94 | $-1.84 | $-1.27 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Preferred Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Earnings Per Share Diluted | $-0.66 | $-0.14 | ||||||||||
| Earnings Per Share Basic | $-0.66 | $-0.14 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Professional Fees | $23.2M | $30.0M | $38.4M | $17.8M | $19.0M | |
| Noncontrolling Interest In Guaranteed Payment | $17.8M | $16.8M | $15.8M | $1.3M | $0.00 | |
| Labor And Related Expense | $16.9M | $65.1M | $45.5M | $48.5M | $128.6M | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $5.6M | $39.1M | $10.1M | $23.2M | $107.8M | |
| Other Expenses | $11.5M | $21.9M | $28.3M | $13.9M | $7.6M | |
| Interest Income Operating Paid In Kind | $494.0K | $446.0K | $359.0K | $881.0K | $875.0K | |
| Paid In Kind Interest | $12.2M | $17.7M | $11.2M | |||
| Interest Income Operating | $44.0K | $457.0K | $412.0K | $7.4M | $2.1M | |
| Stock Issued During The Period Value Share Based Payment Arrangement To Related Party Employees After Forfeitures | $110.0K | $147.0K | $830.0K | $2.9M | ||
| Adjustments To Additional Paid In Capital Dividends To Related Parties | $110.0K | $147.0K | $830.0K | $2.9M | ||
| Financial Instruments Owned At Fair Value | $329.1M | $497.2M | $674.2M | |||
| Additional Paid In Capital | $1.85B | $1.58B | ||||
| Warrants And Rights Outstanding | $178.0K | $0.00 | ||||
| Stock Issued During Period Value New Issues | $673.0K | -$4.3M | $20.1M | $207.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Professional Fees | $4.0M | $5.3M | $8.0M | $5.1M | $7.3M | $5.5M | $5.0M | $6.7M | $10.4M | $8.1M | $14.2M | $7.9M | $5.4M | $4.9M | |
| Noncontrolling Interest In Guaranteed Payment | $4.8M | $4.7M | $4.6M | $4.5M | $4.4M | $4.4M | $4.2M | $4.2M | $4.1M | $4.0M | $3.9M | $3.9M | $3.8M | $0.00 | |
| Labor And Related Expense | $3.0M | $2.4M | $3.3M | $2.9M | $7.1M | $3.9M | $7.3M | $15.4M | $35.8M | $12.7M | $10.5M | $11.6M | $10.1M | $10.9M | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $367.0K | $462.0K | $461.0K | $804.0K | $3.4M | $994.0K | $2.0M | $8.5M | $27.0M | $1.9M | $2.7M | $3.5M | $2.8M | $5.0M | |
| Other Expenses | $2.0M | $2.4M | $2.5M | $2.7M | $2.8M | $3.1M | $5.5M | $5.2M | $6.9M | $7.1M | $6.7M | $7.1M | $6.1M | ||
| Interest Income Operating Paid In Kind | $139.0K | $12.0K | $108.0K | $82.0K | $73.0K | $67.0K | |||||||||
| Paid In Kind Interest | $2.8M | $3.3M | $5.1M | ||||||||||||
| Interest Income Operating | $10.0K | $12.0K | $12.0K | $118.0K | $114.0K | $116.0K | $113.0K | $97.0K | $85.0K | $73.0K | |||||
| Stock Issued During The Period Value Share Based Payment Arrangement To Related Party Employees After Forfeitures | $110.0K | $37.0K | -$37.0K | $120.0K | -$205.0K | ||||||||||
| Adjustments To Additional Paid In Capital Dividends To Related Parties | $110.0K | $37.0K | -$37.0K | $120.0K | -$205.0K | ||||||||||
| Financial Instruments Owned At Fair Value | $205.8M | $244.0M | $263.8M | $291.4M | $334.3M | $335.0M | $331.4M | $378.4M | $457.8M | $489.3M | |||||
| Additional Paid In Capital | $1.88B | $1.86B | $1.86B | $1.84B | $1.84B | $1.84B | $1.85B | $1.84B | $1.84B | $1.58B | |||||
| Warrants And Rights Outstanding | $487.0K | $365.0K | $197.0K | $227.0K | $648.0K | $784.0K | $180.0K | $161.0K | $956.0K | $1.1M | |||||
| Stock Issued During Period Value New Issues | $673.0K | -$1.5M | -$4.3M | $20.1M |
Most recent annual filing with the SEC: September 29, 2025
Data sourced from SEC EDGAR public filings as of August 8, 2026.